GH Secretagogue Blend
CJC-1295 (No DAC) + Ipamorelin
Co-lyophilized GHRH analog and selective ghrelin-receptor agonist blend.
$90.00
Free shipping on orders over $300 · Same-day dispatch before 2PM EST
Select Option
Volume Discounts
Don't forget your reconstitution solution
Bacteriostatic Water 30mL
$14.99
Purchase Options
Lab Verified
HPLC-MS + endotoxin
Same-Day Ship
Orders by 2PM EST
Damage Coverage
Free replacement
Discreet Packaging
Plain outer box
Research Use Only
Not for human or veterinary consumption. For laboratory and in-vitro research purposes only.
Description
A common research blend pairing CJC-1295 (without DAC) with the selective ghrelin-receptor agonist Ipamorelin.
Both peptides supplied co-lyophilized in a single vial. Research use only.
Reconstitution
Reconstitute with bacteriostatic water in your preferred ratio. Store reconstituted vials refrigerated (2–8 °C) and use within recommended timeframes for your protocol.
Storage
Unreconstituted lyophilized powder stable at room temperature for short periods; refrigerate (2–8 °C) for long-term storage. Avoid repeat freeze/thaw cycles.
- Dose
- 5mg + 5mg
- Purity
- ≥ 99%
- Form
- Lyophilized powder
- Storage
- Refrigerate after reconstitution
- Origin
- USA — synthesized & shipped domestically
- Testing
- HPLC-MS, MALDI, endotoxin screen
Research Overview
This co-lyophilized research blend pairs CJC-1295 without the Drug Affinity Complex (a 30-amino-acid GHRH analog) with Ipamorelin, a highly selective pentapeptide ghrelin-receptor agonist.
The combination is used in growth hormone secretagogue research to study simultaneous activation of GHRH and GHS-R1a receptor pathways in pulsatile GH release models.
Mechanism of Action
CJC-1295 (no DAC) binds the GHRH receptor on pituitary somatotrophs while Ipamorelin selectively activates GHS-R1a. The two pathways converge on cAMP-mediated GH release with synergistic amplitude in research models.
Research Applications
- Synergistic GHRH + ghrelin pathway studies
- Pulsatile GH release research
- GH secretagogue blend pharmacology
Reconstitution & Handling
Certificate of Analysis
Lot / Batch
QP-2025-7122
- Product
- CJC-1295 (No DAC) + Ipamorelin
- Manufacture date
- 2025-03-19
- Test date
- 2025-03-22
- Expiration
- 2028-03-19
- Appearance
- White to off-white lyophilized powder
- Identity
- Confirmed — matches reference standard
- Purity (HPLC)
- 99.60%
- Water content (KF)
- 1.40%
- Endotoxin (LAL)
- < 0.07 EU/mg
- Bioburden
- < 1 CFU / vial
- Analytical methods
- RP-HPLC, ESI-MS, MALDI-TOF, LAL endotoxin assay
- Released by
- QPUSA Quality Assurance Lab
